MEDP
Medpace Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MEDP
Article Summary
HOLD- Medpace Holdings Inc. (NASDAQ: MEDP) is being sued for violations of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated by the U.S.
- Securities and Exchange Commission.
- The lawsuit alleges that Medpace Holdings made false and misleading statements to the market, including a lower book-to-bill ratio than expected and cancellations at the highest level in over a year.
- Shareholders who purchased shares during the class period listed are encouraged to contact DJS Law Group regarding possible lead plaintiff appointments.
Free users see 3 BUY signals per day. Premium unlocks all of them, plus instant email alerts.
See Plans
Growth Stock Scoring Breakdown
| METRIC | VALUE | WEIGHT | ANALYSIS |
|---|---|---|---|
| Sales Growth TTM ? | 24.2% | 25% | 70.0 ptsGood (24.2%) - Healthy growth |
| EPS Growth Next 5Y ? | 10.9% | 25% | 35.0 ptsBelow Screener (10.9%) - Modest outlook |
| Target Price Upside ? | 0.9% | 20% | 20.0 ptsMinimal Upside (0.9%) - Target: $453.18 vs Current: $449.35 |
| Gross Margin % ? | 28.0% | 15% | 40.0 ptsModerate (28.0%) - Adequate margins |
| Drawdown from 52-Wk High ? | -28.6% | 15% | 80.0 ptsSolid Dip (-28.6%) - Good entry zone |
Disclaimer: This rating is for informational purposes only and is not financial advice.
All data sourced from Finviz.
Always conduct your own research and consult with a financial advisor before making investment decisions.
Past performance does not guarantee future results.
About MEDP
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
- The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas.
- It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services.
- In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials.
- Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.